Thermage (THRM) Rejects $5.50 Per Share Acquisition Offer
More News related to THRM
- Notable Analyst Rating Changes 12/30: AXYS, RDEN Upgraded; DOW, GHL, THRM Downgraded
- Collins Stewart Downgrades Thermage (THRM) to Hold
- Thermage (THRM) Reports Q3 Loss of $0.03, Misses by 2c; Withdraws FY Outlook
- Thermage (THRM) Issues Guidance Below Street View
- Stanford Starts Medical Equipment & Supplies Stocks (SYK, MNT, ZMH, BEAT, more..)
More News related to Mergers and Acquisitions
- Pepsi (PEP) Company Completes Acquisition of Conway-Myrtle Beach Bottler
- Hershey (HSY), Nestle said to have been in contact about Cadbury (CBY)
- Kraft Singles Itself Out as Buyer for Cadbury
- Brookfield Positions To Bid for General Growth Properties (GGWPQ)
- Euro Regulators May Have Flawed View of Sun (JAVA)/Oracle (ORCL) Deal, Molgen Says; Ellison OK with MySQL Separate Entity
Thermage, Inc. (Nasdaq: THRM) determined to reject the previously announced unsolicited, non-binding proposal to acquire Thermage for $5.50 per share and that Thermage will not enter into discussions with the third party regarding its alternative acquisition proposal to the pending merger with Reliant Technologies, Inc. The Thermage Board determined to pursue closing the Reliant transaction as soon as possible.
Chairman of the Board, President and Chief Executive Officer, Stephen J. Fanning stated, "We are fully committed to our pending merger with Reliant and we find the merits of the proposed combination with Reliant compelling. We believe the proposed merger with Reliant will provide significantly greater value to Thermage stockholders. Our Board believes that the Reliant transaction will enable the company to establish a global leadership position in the aesthetic device industry. Thermage and Reliant have complementary business models and technologies which can provide a broad range of complementary products to both new and existing customers, and offer significant revenue and cost saving synergies."
Thermage, Inc. is engaged in designing, developing, manufacturing and marketing medical devices for the non-invasive treatment of wrinkles. [SM]
Related Categories
Hot ListMergers and Acquisitions
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
